指令
哌拉西林
哌拉西林/他唑巴坦
他唑巴坦
医学
管理(神学)
抗生素
重症监护医学
医疗急救
急诊医学
政治学
计算机科学
法学
微生物学
细菌
铜绿假单胞菌
程序设计语言
政治
生物
遗传学
作者
Frederik Novak,Jens Thusgård Hørlück,Jacob Dvinge Redder,Paul W. Denton,Merete Storgaard
标识
DOI:10.1016/j.ijid.2021.01.029
摘要
BackgroundIn April 2017, the Central Denmark Region Antibiotic Stewardship Committee issued a directive to reduce the general use of piperacillin-tazobactam and prescribe narrow-spectrum antibiotics for mild and moderate pneumonia. The directive was distributed to all regional hospital clinicians.MethodsElectronic medical records were used to obtain de-identified details of all antibiotics administered (together with diagnosis codes) to all in-hospital patients (pre-directive and post-directive) in the nine regional hospitals. Average moving range statistical process control charts were used to analyze pre-directive and post-directive variation in antibiotic usage patterns.ResultsUpon the distribution of the directive, a period of decline of the overall usage of piperacillin-tazobactam ensued. Rather than benzylpenicillin, as recommended for pneumonia, the initial decline in piperacillin/tazobactam usage was accompanied by increased use of cefuroxime.ConclusionsA steward-directed reduction in piperacillin-tazobactam usage was accompanied by less desirable usage of a broad-spectrum alternative. Future antibiotic stewardship initiatives will hopefully benefit from close monitoring and timely feedback to clinicians. A dialogue with clinicians based on near real-time data is predicted to improve antibiotic stewardship actions.
科研通智能强力驱动
Strongly Powered by AbleSci AI